Skip to main content
. 2022 Mar 16;13:831359. doi: 10.3389/fpsyt.2022.831359

TABLE 2.

Relative risk of QTc prolongation with frequently used antipsychotic drugs [modified according to Refs. (132, 86)].

Substance Risk of QTc prolongation
Thioridazine, pimozide, sertindole, haloperidol (i.m., IV, high dose), iloperidone, melperone, amisulpride, ziprasidone +++
Chlorpromazine, levomepromazine, quetiapine, sulpiride ++
Haloperidol (p.o.), fluphenazine, perphenazine, promethazine, pipamperone, chlorprothixene, olanzapine, risperidone, asenapine, clozapine +
Aripiprazole, brexpiprazole, cariprazine, lurasidone, paliperidone, lumateperone ±

+++, high (>20 ms); ++, moderate (10–20 ms); +, low (<10 ms); ±, very low (< 10 ms, potentially not higher than placebo).